INVO Fertility (IVF) Net Cash Flow Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 20.16% |
| Jun 30, 2025 | -17.63% |
| Mar 31, 2025 | 16.12% |
| Dec 31, 2024 | 18.63% |
| Sep 30, 2024 | 5.69% |
| Jun 30, 2024 | 26.41% |
| Mar 31, 2024 | -38.88% |
| Dec 31, 2023 | -19.65% |
| Sep 30, 2023 | 49.52% |
| Jun 30, 2023 | -38.14% |
| Mar 31, 2023 | 193.42% |
| Dec 31, 2022 | -83.12% |
| Sep 30, 2022 | -150.98% |
| Jun 30, 2022 | -144.31% |
| Mar 31, 2022 | -74.89% |
| Dec 31, 2021 | 61.98% |
| Sep 30, 2021 | -102.26% |
| Jun 30, 2021 | -77.97% |
| Mar 31, 2021 | -89.42% |
| Dec 31, 2020 | 89.36% |
| Sep 30, 2020 | -80.29% |
| Jun 30, 2020 | 83.71% |
| Mar 31, 2020 | -173.85% |
| Dec 31, 2019 | -130.05% |
| Sep 30, 2019 | -207.94% |
| Jun 30, 2019 | -210.40% |
| Mar 31, 2019 | 205.51% |
| Dec 31, 2018 | -102.31% |
| Sep 30, 2018 | -103.58% |
| Jun 30, 2018 | 236.47% |
| Mar 31, 2018 | 28.35% |
| Dec 31, 2017 | 14.26% |
| Sep 30, 2017 | 45.67% |
| Jun 30, 2017 | -22.03% |
| Mar 31, 2017 | -197.99% |
| Dec 31, 2016 | -125.11% |
| Sep 30, 2016 | -50.18% |